Loading market dashboard
Alto Ingredients, Inc.
ALTOBasic MaterialsNASDAQUS
Loading disclosure news
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
Alto Ingredients (ALTO) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
Alto Ingredients (ALTO) produces specialty alcohols for industry and is trading at a significant discount to sector medians, with forward EV/sales at 0.54x. ALTO's Q1 earnings beat expectations, with adjusted EBITDA swinging to $4.7M from a $4.4M loss, and gross profit rising to $9.2M from -$1.8M. Management is executing a turnaround strategy, improving essential ingredient returns, and planning a debottlenecking project to boost capacity by 8%.
ALTO, BMA and GCO made it to the Zacks Rank #1 (Strong Buy) value stocks list on June 3rd, 2026.
ALTO's essential ingredients return rises to 53.4% in Q1 2026, aided by higher co-product pricing and lower corn costs, even as volumes decline.
Here is how Alto Ingredients (ALTO) and Hugo Boss (BOSSY) have performed compared to their sector so far this year.
PEKIN, Ill., May 18, 2026 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a producer and distributor of renewable fuels, essential ingredients and specialty alcohols, announced that management is scheduled to participate at the Craig-Hallum 23rd Annual Institutional Investor Conference on Thursday, May 28, 2026, in Minneapolis, MN.
ALTO, LSCC and INTT made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on May 15th, 2026.
Alto Ingredients (ALTO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
ALTO, STRL and LSCC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on May 11th, 2026.
Here is how Alto Ingredients (ALTO) and Hugo Boss (BOSSY) have performed compared to their sector so far this year.
Alto Ingredients, Inc. (ALTO) Q1 2026 Earnings Call Transcript
Alto Ingredients (ALTO) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of a loss of $0.08 per share. This compares to a loss of $0.16 per share a year ago.
Q1 2026 Gross Profit of $9.2 Million Increased $11.0 Million Q1 2026 Net Income of $4.0 Million, or $0.05 per Share, Improved $16.0 Million Q1 2026 Adjusted EBITDA of $4.7 Million Improved $9.1 Million Compared to Q1 2025 PEKIN, Ill., May 06, 2026 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a producer and distributor of renewable fuels, essential ingredients and specialty alcohols, reported its financial results for the quarter ended March 31, 2026.
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)---- $anro #cns--Alto Neuroscience, Inc. (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on precision medicines for neuropsychiatric disorders, today announced the presentation of data from a randomized, single-blind, placebo-controlled Phase 2a trial of ALTO-207 (formerly CTC-501) in patients with Major Depressive Disorder (MDD). The data were presented in a poster session at the 2026 Annual Meeting of the Society of Biological Psychiatry (SOBP). ALTO-20.
Alto Ingredients (ALTO) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
PEKIN, Ill., April 30, 2026 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO) a producer and distributor of renewable fuels, essential ingredients and specialty alcohols, announced it will release its first quarter 2026 financial results after the close of market on Wednesday, May 6, 2026.
Alto Ingredients has rebounded over 300% since 2023, driven by operational turnaround and strategic execution after a period of severe headwinds. Cost reductions, the accretive Alto Carbonic acquisition, and the ability to earn 45z credits have transformed ALTO's earnings power and margin profile. Exporting renewable fuel at premium prices has become a structural earnings driver, with forward contracts secured into 2026 and with accelerating volumes.
Here is how Alto Ingredients (ALTO) and Central Garden (CENT) have performed compared to their sector so far this year.
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)---- $anro #cns--Alto Neuroscience, Inc. (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on precision medicines for neuropsychiatric disorders, today announced the initiation of a Phase 2b randomized, placebo-controlled trial of ALTO-207 in treatment-resistant depression (TRD), a program designed to replicate the strongly positive PAX-D study results and support a streamlined path to registration. TRD is estimated to affect up to 7 million adults in the U.
ALTO is pivoting from commodity ethanol to specialty alcohols, carbon capture and 45Z credits-driving shares up 71.6% year to date.
Alto Ingredients (ALTO) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Here is how Alto Ingredients (ALTO) and Central Garden (CENTA) have performed compared to their sector so far this year.
One area of Wall Street that investors might want to start buying into in April are strong, best-in-class, cheap stocks trading under $10 a share.
Alto Ingredients' losses since 2022 are easing as cost cuts, idling of plants and CO2 monetization aim to support a gradual margin recovery.
Alto Ingredients (ALTO) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Alto Ingredients (NASDAQ: ALTO - Get Free Report) and Olaplex (NASDAQ: OLPX - Get Free Report) are both small-cap consumer discretionary companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, risk and dividends. Analyst Ratings This is a breakdown of
Maison Solutions (NASDAQ: MSS - Get Free Report) and Alto Ingredients (NASDAQ: ALTO - Get Free Report) are both small-cap consumer discretionary companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, institutional ownership, analyst recommendations, risk, valuation, dividends and profitability. Valuation and Earnings This table compares
ALTO's Marketing and Distribution unit drove $221M sales in 2025, stabilizing revenue while pushing into higher-value alcohol markets.
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Alto Neuroscience, Inc. (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on precision medicines for neuropsychiatric disorders, today announced topline data from its Phase 2 proof-of-concept (POC) clinical trial evaluating ALTO-101 for the treatment of cognitive impairment associated with schizophrenia (CIAS), and provided an update on the Company's pipeline and prioritization. ALTO-101 did not achieve statistical significance on primary e.
ALTO trades at a premium, but its pivot to specialty alcohols, carbon credits and cost discipline could fuel growth despite commodity risks.
Alto Ingredients (NASDAQ: ALTO - Get Free Report) and Real Brands (OTCMKTS:RLBD - Get Free Report) are both consumer discretionary companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, analyst recommendations, earnings, risk and profitability. Profitability This table compares Alto Ingredients and
Real Brands (OTCMKTS:RLBD - Get Free Report) and Alto Ingredients (NASDAQ: ALTO - Get Free Report) are both small-cap consumer discretionary companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, profitability, institutional ownership and earnings. Volatility and Risk Real Brands has
Here is how Alto Ingredients (ALTO) and Central Garden (CENTA) have performed compared to their sector so far this year.
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, March 23, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor.
PEKIN, Ill., March 23, 2026 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a producer and distributor of renewable fuel, essential ingredients and specialty alcohols, today announced that management will take part in the H.C. Wainwright Renewable Fuels Virtual Day on Wednesday, March 25, 2026.
ACEL, CROX, ALTO and DLB gain appeal as easing inflation boosts rate-cut hopes and earnings estimates climb for these consumer discretionary picks.
As of March 9, 2026, three stocks in the materials sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Strong improvement in fiscal performance has sent Alto Ingredients up 180% over the past year. Continued capacity expansion is well-cited as a possible catalyst for shares, but another catalyst remains in motion for this industrial alcohol and renewable energy company. That would be Alto's potential to get acquired by a smaller competitor.
Kid Brands (OTCMKTS:KIDBQ - Get Free Report) and Alto Ingredients (NASDAQ: ALTO - Get Free Report) are both consumer discretionary companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, profitability, institutional ownership, valuation, dividends, analyst recommendations and risk. Earnings and Valuation This table compares Kid
Reynolds Consumer Products (NASDAQ: REYN - Get Free Report) and Alto Ingredients (NASDAQ: ALTO - Get Free Report) are both consumer discretionary companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, valuation, institutional ownership, dividends, risk, analyst recommendations and earnings. Analyst Ratings This is a breakdown
Alto Ingredients Inc (NASDAQ: ALTO) shares are trading higher again Friday, extending a powerful two-day rally after the ethanol and specialty alcohol producer's blowout earnings report late Wednesday sparked a roughly 50% surge on Thursday. Here's what investors need to know.
ALTO, SHG and ESCA made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 6, 2026.
Alto Ingredients reported strong fourth-quarter results with profitability well ahead of consensus expectations. Management attributed the outperformance to a combination of improved crush margins, high-margin export sales, lower operating expenses, and the recognition of clean fuel production tax credits. While Q1 will be impacted by seasonality and weather-related downtime, 2026 as a whole should benefit from strong export volumes and a doubling of tax credits.
